Author(s):
Kavitha K, Srinivasan N, Suresh R, Mohan S
Email(s):
kavithakrocks@gmail.com , kavitha@kcp.edu.in
DOI:
10.52711/0974-360X.2023.00407 
Address:
Kavitha K1,2*, Srinivasan N1, Suresh R1, Mohan S2
1Department of Pharmacy, Faculty of Engineering and Technology, Annamalai University, Annamalai Nagar, Tamil Nadu.
2Department of Pharmaceutical Chemistry, Karpagam College of Pharmacy, Ottakalpandapam, Coimbatore, Tamil Nadu.
*Corresponding Author
Published In:
Volume - 16,
Issue - 5,
Year - 2023
ABSTRACT:
Quinazolin-4-one have been used to therapy a lot of afflictions of humans legendary works exemplify that it possesses various biological activities. In this research is proposed to discover the synthetic derived pyrazolone fused quinazolin-4-one and Spike protein of sars Co V II and to understand the Insilico molecular origin of its activity. Even though chemistry of quinazolin 4 one being as an recognized area , day by day newer more complex derivatives are still being discovered. Moreover, an assortment of prose quinazolinone exibits a strong lactam-lactim tautomeric interaction and further when the methyl group is present in the second position, the tautomeric effect is increased, including structural activity relationship studies of the ring system describe that the position 2,6,8 are very much important for structure activity studies as well as inclusion of different heterocyclic moieties at position 3 could be enhances the different types of biological activity as well as Antiviral activity. The newly designed and synthesized compounds which is subjected to docking analysis as well as Computational study was performed using Auto dock 4, soon after admetSAR, also pkCSM Servers, were used to investigate drug likeness prophecy. This study suggested that the designed novel pyrazolone fused quinazolin-4-one derivatives (QPZ1-QPZ5) which are likely against the Sars COV-2 enzymes with excellent binding affinity , further obey’s Lipinski rule. Utilizing contemporary strategies, these novel synthetic molecule origins might establish a reliable medication or support potential lead identification. Identified potential compounds can be further taken for experimental studies, spectral analysis.
Cite this article:
Kavitha K, Srinivasan N, Suresh R, Mohan S. In Silico Identification of Potential Inhibitors of Substituted Quinazolin-4-One against Main Protease and Spike Glycoprotein of Sars Cov-2. Research Journal of Pharmacy and Technology 2023; 16(5):2470-6. doi: 10.52711/0974-360X.2023.00407
Cite(Electronic):
Kavitha K, Srinivasan N, Suresh R, Mohan S. In Silico Identification of Potential Inhibitors of Substituted Quinazolin-4-One against Main Protease and Spike Glycoprotein of Sars Cov-2. Research Journal of Pharmacy and Technology 2023; 16(5):2470-6. doi: 10.52711/0974-360X.2023.00407 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-5-66
REFERENCES:
1. Corman V, Lienau J, Witzenrath M.Coronaviruses as the cause of respiratory infections. Der Internist.Corona viruses as the cause of respiratory infections. Der Internist. 2019:60(11):1136-1145. https://doi.org/10.1007/s00108-019-00671-5
2. Desai NC, Amit Dodiya, Niraj Shihory. Synthesis and antimicrobial activity of novel quinazolinone-thiazolidine-quinoline compounds. Journal of Saudi Chemical Society. 2013: 17:259-267. https://doi.org/10.1016%2Fj.jscs.2011.04.001
3. Lai MM, Cavanagh D.The molecular biology of corona viruses. Adv virus Res. 1997: 48: 1-100. https://doi.org/10.1016/S0065-3527(08)60286-9
4. De Wit, E., Van Doremalen, N., Falzarano D, Munster VJ.SARS and MERS: recent insights into emerging corona viruses. Nat Rev Microbial. 2016: 14: 523-534. https://doi.org/10.1038/nrmicro.2016.81
5. Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS like corona Viruses Science. 2005: 310: 676-679. https://doi.org/10.1126/science.1118391
6. Guan Y, Zheng B.J, Guan He YQ, Liu X.L, Cheung C.L, Luo S.W, et al. Isolation and characterization of viruses related to the SARS corona virus from animals in southern china. Science (New York, N.Y). 2003: 302(5643): 276-278. https://www.ncbi.nlm.nih.gov/books/NBK92471
7. Chan J.F-W, Yuan S, Kok K-H, To, K.K.-W, Chu H, Yang J, Xing F, ‘et al’. A familial cluster of pneumonia associated with the 2019 novel corona virus indicating person-to-person transmission: A study of a family cluster. Thelancet. 2020: 395(10223): 514-523.https://doi.org/10.1016/S0140-6736(20)30184-7,and https://doi.org/10.1016/ S0140-6736(20)30185-9
8. Munster VJ, Koopmans M, Van Doremalen, Van Riel D, and de Wit E. A novel corona virus emerging in china-key questions for impact assessment. New England Journal of Medicine. 2020: 382(8): 692-694. https://doi.org/10.1056/nejmp2000929
9. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, ‘et al’.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor cell.2020:181(2):271-280. https://doi.org/10.1016/j.cell.2020.02.052
10. Hassan A, Paray BA, Hussian A, Qadir FA, Attar Aziz FM, ‘et al’. A review on the cleavage priming of the spike protein on corona virus by angiotensin-converting enzyme-2 and furin.Journal of Biomolecular structure and Dynamics. 2020:1-13. https://doi.org/10.1080/07391102.2020.1754293
11. GeX Y, Li JL, Yang XL,Chmura AA,Zhu G, Epstein JH, ‘et al’. Isolation and characterization of a bat SARS-like corona virus that virus that uses the ACE2 receptor.Nature. 2013:503(7477):535-538. https://doi.org/10.1038/nature12711
12. Menachery VD, Dinnon KH, Yount BL, McAnarney ,ET., Gralinski, LE, Hale A,et al.Trypsin treatment unlocks barrier for zoonotic bat corona virus infection. Journal of Virology. 2019: 94(5): e01774-19. https://doi.org/10.1128%2FJVI.01774-19
13. Boopathi S, Poma AB, and Kolandaivel SP. Novel 2019 corona virus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics. 2020: 1-14. https://doi.org/10.1080/07391102.2020.1758788
14. Khan SA, Zia K, Ashraf S, Uddin R, and Ul-Haq Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics. 2020: 1-13. https://doi.org/10.1080/07391102.2020.1751298
15. Hilgenfeld R. From SARS to MERS: Crystallographic studies on corona viral proteases enable antiviral drug design. The FEBS Journal, 2014: 281(18): 4085-4096. https://doi.org/10.1111/febs.12936
16. Neddle D, Lountos, GT., Waugh, DS. Structures of the Middle East respiratory syndrome corona virus 3C like protease reveal insights into substrate specificity. Acta Crrystallography. 2015: D71:1102-11. https://doi.org/10.1107/s1399004715003521
17. ChunckCP, ChowHF, WanDC, WongKB. Profiling of substrate specificities of 3C like Proteases from group 1,2a,2b, and 3 corona viruses. PLoS one. 2011: 6: e27228. https://doi.org/10.1080/14756366.2019.1690480
18. Khan RJ, Jha RK, Amera G, Jain M, Singh E, Pathak A, Singh RP, ‘et al. Targeting SARS-CoV-2. A systematic drug repurposing approach to identify promising inhibitors against 3C-like Proteinase and 2’-O-Ribosemethyltransferase.Journal of Biomolecular Structure and Dynamics. 2020: 1-40. https://doi.org/10.1080/07391102.2020.1753577
19. ZhangL,LinD,SunX,CurthU,DrostenC,Sauerhering L, Becker S, et al. Crystal structure of SARS-CoV-2 main Protease provides a basis for design of improved a-ketoamide inhibitors. Science. 2020: 368(6489): 409-412. https://doi.org/10.1126/science.abb3405
20. Datta AK, Datta R, Sen B. Anti parasitic chemo therapy: tinkering with the purine salvage pathway. Adv Exp Med Biol. 2008: 625: 116-132. https://doi.org/10.1007/978-0-387-77570-8_10
21. Rajasekhar KK, Nizamuddin abdrrahman Shemsu Surur ND, Yennus Tadesse Mekonnen. Synthesis, characterization, anti tubercular and anti bacterial activity and molecular docking of 2, 3-di substituted quinazolinone derivative. Research and Reports in Medicinal Chemistry. 2016: 6:15-26. https://doi.org/10.2147/RRMC.S91474
22. Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, and Tang Y. Admet SAR: A comprehensive source and free tool for assessment of chemical ADMET properties. ACS Publications. https://doi.org/10.1021/ci300367a
23. Sinha SK, Shakya, Prasad SK, Singh S, Gurav NS, Prasad RS and Gurav SS. An in-silico valuation of different saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics. 2020:1-13. https://doi.org/10.1080/07391102.2020.1762741
24. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. Journal of Med Chem. 2002: 45: 2615-2623. http://dx.doi.org/10.1021/jm020017n
25. Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as sum of fragment-based contributions its application to the prediction of drug transport properties Med Chem. 2000: 43:3714-3717. https://doi.org/10.1021/jm000942e